Literature DB >> 7358767

[Prognosis of metastatic renal cell carcinoma related to the pattern of metastasis (author's transl)].

B Bohnenkamp, W Rhomberg, W Sonnentag, U Feldmann.   

Abstract

Hundred nine unselected patients with metastatic renal cell carcinoma have been stratified into 3 groups according to their type of metastasis: 17 patients with sceletal involvement only, 67 patients with visceral metastases, and 21 patients with a mixed type of metastasis. Four patients with a locoregional pattern of recurrence were not included in the analysis. The survival data (evaluated by life table analysis and a modified Wilcoxon-Rang-test) revealed a better prognosis for patients presenting exclusively with osseous metastases compared to the group with visceral metastases. The patients with osseous metastases showed a median survival time from diagnosis of 29.9 months compared to 11.6 months in patients with visceral involvement. Considering only patients whose metastases have been detected after a period of latency post nephrectomy, there is a further increase in the survival in favour of the patients with sceletal metastases and the difference to the group with visceral metastases becomes statistically highly significant.

Entities:  

Mesh:

Year:  1980        PMID: 7358767     DOI: 10.1007/bf00412901

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  12 in total

1.  Hormones in the treatment of metastatic renal cancer.

Authors:  A Morales; G Kiruluta; S Lott
Journal:  J Urol       Date:  1975-11       Impact factor: 7.450

2.  THE SIGNIFICANCE OF CYTOPLASMIC GRANULARITY IN THE PROGNOSIS OF RENAL CELL CARCINOMA.

Authors:  G P MURPHY; F K MOSTOFI
Journal:  J Urol       Date:  1965-07       Impact factor: 7.450

3.  Factors in the prognosis of carcinoma of the kidney.

Authors:  E W RICHES
Journal:  J Urol       Date:  1958-02       Impact factor: 7.450

4.  Is nephrectomy justified in patients with metastatic renal carcinoma?

Authors:  D E Johnson; K E Kaesler; M L Samuels
Journal:  J Urol       Date:  1975-07       Impact factor: 7.450

5.  Parenchymal carcinoma of the kidney.

Authors:  I H GRIFFITHS; A C THACKRAY
Journal:  Br J Urol       Date:  1949-06

6.  [Control studies on the cytostatic combination therapy in metastasizing breast carcinoma].

Authors:  K W Brunner; G Martz; H J Senn; P Obrecht; P Alberto; F Melchert
Journal:  Internist (Berl)       Date:  1973-12       Impact factor: 0.743

7.  Hormonal therapy of renal carcinoma alone and in association with cytostatic drugs.

Authors:  P Alberto; H J Senn
Journal:  Cancer       Date:  1974-05       Impact factor: 6.860

8.  Classification of patients with disseminated cancer of the breast.

Authors:  S J Cutler; J A Ardyce; S G Taylor
Journal:  Cancer       Date:  1969-11       Impact factor: 6.860

9.  Renal cell carcinoma. Natural history and results of treatment.

Authors:  S Rafla
Journal:  Cancer       Date:  1970-01       Impact factor: 6.860

10.  Papillary renal cell carcinoma: a clinical, radiologic, and pathologic study of 34 cases.

Authors:  R Mancilla-Jimenez; R J Stanley; R A Blath
Journal:  Cancer       Date:  1976-12       Impact factor: 6.860

View more
  1 in total

1.  [Surgical treatment of osseous metastases of the pelvis].

Authors:  S Bading; E Mössinger; S Baus; L Bastian
Journal:  Unfallchirurg       Date:  2004-05       Impact factor: 1.000

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.